Guggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60
3 days agoGuggenheim analyst Yatin Suneja initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $60.
Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Algonquin Power & Utilities (AQN) delivered earnings and revenue surprises of +10.00% and +1.98%, respectively, for the quarter ended September 2026. ...
Atmus Filtration (ATMU) delivered earnings and revenue surprises of +4.05% and +1.08%, respectively, for the quarter ended September 2026. Do the numb...
KLX Energy Services Holdings, Inc. (KLXE) Q3 2026 Earnings Call November 6, 2026 9:00 AM ESTCompany ParticipantsChristopher Baker - President, CEO &.....
Orion Properties Inc. (ONL) Q3 2026 Earnings Call November 6, 2026 10:00 AM ESTCompany ParticipantsPaul Hughes - General Counsel & SecretaryPaul...
Wells Fargo analyst Constantine Lednev maintains Northwest Natural Hldg (NYSE:NWN) with a Equal-Weight and raises the price target from $49 to $50.
Kingstone Companies, Inc. (KINS) Q3 2026 Earnings Call November 6, 2026 8:30 AM ESTCompany ParticipantsStefan NorbomMeryl Golden - President, CEO &...
Fidus Investment (FDUS) Q3 2026 Earnings Call November 6, 2026 9:00 AM ESTCompany ParticipantsJody Burfening - Investor Relations ContactEdward Ross -...
Western Digital has substantially outpaced the broader market over the past year, with Wall Street analysts maintaining a highly bullish outlook on it...
B. Riley Securities analyst Mayank Mamtani reiterates Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $18 to $16.
Key TakeawaysCredo fell 17. 7% to $112 on Thursday and 25.
Citizens analyst Andrew Boone maintains Warby Parker (NYSE:WRBY) with a Market Outperform and raises the price target from $29 to $40.
BOOM, DINO, CVE, ZIM and PKX stand out with attractive EV-to-EBITDA ratios and strong earnings outlook.
Wells Fargo analyst Michael Turrin maintains Blend Labs (NYSE:BLND) with a Overweight and lowers the price target from $3 to $2.
Cabot's Q4 earnings beat estimates as Performance Chemicals growth offset Reinforcement Materials pressure, with fiscal 2027 adjusted EPS projected at...
B. Riley Securities analyst Craig Ellis maintains Microchip Technology (NASDAQ:MCHP) with a Buy and lowers the price target from $98 to $85.
Loading...
